|
Sofosbuvir Impurity 26
|
索非布韋雜質(zhì)26
|
|
|
Pramipexole Formaldehyde Adduct Impurity
|
普拉克索甲醛加合物雜質(zhì)
|
|
|
1-Phenyl-3,4-dihydroisoquinoline
|
1-苯基-3,4-二氫異喹啉
|
52250-50-7
|
|
Solifenacin N-Oxide
|
索利那新N-氧化物
|
180272-28-0
|
|
Sofosbuvir Impurity 33
|
((2R,3R,4R)-3-(苯甲酰氧基)-4-氯-4-甲基-5-氧代四氫呋喃-2-基)甲基苯甲酸甲酯
|
1496551-65-5
|
|
Sofosbuvir Impurity 25
|
索非布韋雜質(zhì)25
|
|
|
Pramipexole Impurity 17
|
普拉克索雜質(zhì)17
|
|
|
Sofosbuvir Impurity 40
|
索非布韋雜質(zhì)40
|
|
|
Solifenacin Impurity 1
|
鹽酸溴己新雜質(zhì)1
|
1243274-81-8
|
|
Pramipexole Impurity 25
|
普拉克索雜質(zhì)25
|
|
|
Sofosbuvir Impurity 5
|
|
|
|
Pramipexole Impurity 18
|
普拉克索雜質(zhì)18
|
|
|
Sofosbuvir Impurity 22 (GS-491241)
|
|
|
|
Pramipexole Impurity 56
|
普拉克索雜質(zhì)56
|
|
|
Pramipexole Impurity V
|
(6S)-2-氨基-6-丙酰氨基四氫苯并噻唑
|
106006-84-2
|
|
Solifenacin Related Compound 4 Succinate
|
索非那新琥珀酸相關(guān)物質(zhì)4
|
862207-71-4
|
|
Sofosbuvir Impurity 17
|
索非布韋雜質(zhì)17
|
|
|
Pramipexole Impurity 5
|
普拉克索雜質(zhì)5
|
|
|
Pramipexole Impurity 30
|
普拉克索雜質(zhì)30
|
|
|
Pramipexole Related Impurity 1
|
普拉克索相關(guān)雜質(zhì)1
|
|
|
Pramipexole Impurity 2
|
普拉克索雜質(zhì)2
|
104617-75-6
|
|
Pramipexole Impurity 15
|
普拉克索雜質(zhì)15
|
|
|
Pramipexole Impurity 33
|
2-氨基-6-甲砜基苯并噻唑
|
17557-67-4
|
|
4-Hydroxy Solifenacin (trans, Mixture of (1R,4R) and (1S,4S) Diastereomers)
|
|
|
|
Solifenacin Related Compound 9
|
(R)-1-苯基-1,2,3,4-四氫異喹啉
|
180272-45-1
|
|
Solifenacin Related Compound 3 Succinate
|
索非那新琥珀酸相關(guān)物質(zhì)3
|
862207-70-3
|
|
N-Carbobenyloxy Pramipexole
|
N-CARBOBENYLOXY PRAMIPEXOLE
|
|
|
Pramipexole Impurity 52
|
普拉克索雜質(zhì)
|
1254579-15-1
|
|
Sofosbuvir Impurity 3
|
|
|
|
Sofosbuvir Impurity 14
|
索非布韋雜質(zhì)14
|
|
|
Solifenacin Related Compound 7
|
索利那新USP雜質(zhì)7
|
|
|
Pramipexole Related Impurity 2
|
普拉克索相關(guān)雜質(zhì)2
|
|
|
Pramipexole Impurity 1
|
Pramipexole DBTA Impurity
|
1821389-09-6
|
|
Pramipexole Impurity 45
|
3,4-二甲氧基苯磺酰胺
|
4570-41-6
|
|
Pramipexole Impurity 54
|
6-乙酰胺基-2-氨基-4,5,6,7-四氫苯并噻唑
|
104617-51-8
|
|
Pramipexole Impurity 42
|
2,6-二氨基-4,5,6,7-四氫苯并噻唑
|
106006-83-1
|
|
Pramipexole Impurity 48
|
外消旋N-丙基-2-氰基亞胺基吡咯烷-5-乙酸
|
1246833-75-9
|
|
Pramipexole Impurity 50
|
R-鹽酸普拉克索
|
908244-04-2
|
|
Pramipexole Impurity 35
|
普拉克索雜質(zhì)35
|
1867177-06-7
|
|
Solifenacin EP Impurity B
|
索利那新雜質(zhì) 1
|
1353274-25-5
|
|
Solifenacin Impurity (4-Nitrophenyl (1S)-1-Phenyl-3-4-Dihidroisoquinoline-2(1H)-Carboxylate)
|
索利那新雜質(zhì)2
|
1229227-22-8
|
|
Solifenacin Related Compound 15
|
索利那新雜質(zhì)15
|
|
|
Solifenacin Related Compound 29
|
索利那新雜質(zhì)29
|
861998-77-8
|
|
Sofosbuvir Impurity 7
|
|
|
|
4-Hydroxy Solifenacin N-Oxide (trans, Mixture of (1R,4R) and (1S,4S) Diastereomers)
|
|
|
|
Solifenacin N-Glucuronide
|
索利那新N-葡糖苷酸
|
|
|
Sodium Phenylbutyrate
|
4-苯基丁酸鈉鹽
|
1716-12-7
|
|
Pramipexole Impurity 47
|
順式消旋-7-羥基普拉克索
|
1001648-71-0
|
|
Pramipexole Impurity 29
|
(S)-4,5,6,7-四氫-N2,N6-丙?；?2,6-苯并噻唑二胺
|
1346617-47-7
|
|
2-Amino-6-Bromo-5 ,6-Dihydrobenzo[d]thiazol-7(4H)-One
|
2-氨基-6-溴-7-氧代-4,5,6,7-四氫苯并噻唑
|
1001648-73-2
|
|
Sofosbuvir Impurity 31
|
1015073-42-3
|
1015073-42-3
|
|
Pramipexole Dimer Impurity II
|
PraMipexole DiMer IMpurity II
|
2206826-82-4
|
|
Sofosbuvir Impurity 24
|
索非布韋雜質(zhì)24
|
|
|
Sofosbuvir Impurity 38
|
索非布韋雜質(zhì)38
|
|
|
Sofosbuvir Impurity 43
|
索非布韋雜質(zhì)43
|
|
|
Pramipexole Impurity 6
|
普拉克索雜質(zhì)6
|
|
|
Pramipexole Impurity 22
|
普拉克索雜質(zhì)22
|
|
|
Pramipexole Impurity 32
|
|
|
|
Pramipexole Related Impurity 3
|
普拉克索相關(guān)雜質(zhì)3
|
|
|
Pramipexole Impurity 21
|
普拉克索雜質(zhì)21
|
|
|
(S)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline
|
(S)-1-苯基-1,2,3,4-四氫異喹啉
|
118864-75-8
|
|
Pramipexole Impurity 41
|
|
|
|
Pramipexole Dimer Impurity (Mixture of Diastereomers)
|
普拉克索二聚物雜質(zhì)(非對映體混合物)
|
|
|
Solifenacin Related Compound 33
|
索利那新雜質(zhì)
|
1956436-64-8
|
|
Sofosbuvir Impurity 6
|
索非布韋雜質(zhì)6
|
|
|
Pramipexole Related Impurity 4
|
普拉克索相關(guān)雜質(zhì)4
|
|
|
Pramipexole Impurity 12
|
普拉克索雜質(zhì)12
|
|
|
Pramipexole Impurity 31
|
N-(2-Amino-4,5,6,7-tetrahydro-benzothiazol-6-yl)-acrylamide
|
|
|
Sofosbuvir Impurity 10
|
|
1910099-17-0
|
|
Solifenacin Related Compound 8
|
(S)-1-苯基-1,2,3,4-四氫-2-異喹啉甲酸乙酯
|
180468-42-2
|
|
Sofosbuvir Impurity 8
|
索非布韋雜質(zhì)8
|
944476-44-2
|
|
Solifenacin Related Compound 14
|
索利那新雜質(zhì)14
|
605696-10-4
|
|
Sofosbuvir Impurity 27
|
索非布韋雜質(zhì)27
|
|
|
Solifenacin EP Impurity D
|
索利那新雜質(zhì)D
|
|
|
Pramipexole Impurity 19
|
普拉克索雜質(zhì)19
|
|
|
Sofosbuvir Impurity 42
|
索非布韋雜質(zhì)42
|
|
|
Solifenacin Related Compound 13
|
Solifenacin Related Compound 13
|
1251905-45-9
|
|
Solifenacin Related Compound 16
|
索利那新相關(guān)化合物16
|
|
|
Pramipexole Impurity 46
|
2-氨基苯并噻唑
|
136-95-8
|
|
Solifenacin
|
索非那新
|
242478-37-1
|
|
Pramipexole Impurity D
|
普拉克索雜質(zhì)D
|
104632-27-1
|
|
Solifenacin Related Compound 5
|
索利那新相關(guān)物質(zhì)5
|
|
|
Sofosbuvir Impurity 28
|
索非布韋雜質(zhì)28
|
|
|
Pramipexole Impurity 16
|
普拉克索雜質(zhì)16
|
1373869-91-0
|
|
Pramipexole Impurity 51
|
普拉克索雜質(zhì) 15
|
1965329-42-3
|
|
Pramipexole Impurity 24
|
普拉克索雜質(zhì)24
|
|
|
Pramipexole Impurity 36
|
普拉克索雜質(zhì)36
|
|
|
Sofosbuvir Impurity 16
|
|
|
|
Pramipexole Impurity 14
|
普拉克索雜質(zhì)14
|
|
|
Pramipexole Impurity 27
|
普拉克索雜質(zhì)27
|
2744063-34-9
|
|
Sofosbuvir Impurity 37 ( Sofosbuvir Isomer)
|
索非布韋對映異構(gòu)體
|
|
|
Pramipexole Impurity 20
|
(R)-N-(2-氨基-4,5,6,7-四氫苯并噻唑-6-基)-丙酰胺
|
106006-85-3
|
|
Pramipexole Impurity 44
|
|
|
|
Sofosbuvir Impurity 15
|
N-[(S)-(2,3,4,5,6-五氟苯氧基)苯氧基磷?；鵠-L-丙氨酸異丙酯
|
1334513-02-8
|
|
2, 6-Diamino-5 ,6-Dihydrobenzo[d]thiazol-7(4H)-One
|
普拉克索雜質(zhì)
|
1391053-80-7
|
|
Solifenacin Related Compound 2 Succinate
|
索非那新琥珀酸相關(guān)物質(zhì)2
|
1262506-09-1
|
|
Sofosbuvir Impurity 32
|
(2S)-3,5-二-O-苯甲?；?2-氟-2-C-甲基-D-核糖酸-C-內(nèi)酯
|
1157884-58-6
|
|
Sofosbuvir Impurity 21
|
索非布韋雜質(zhì)21
|
1496552-50-1
|
|
Sofosbuvir Impurity 36
|
索非布韋雜質(zhì)36
|
|
|
Pramipexole Impurity 4
|
普拉克索雜質(zhì)4
|
|